In an 86‑year‑old patient with persistent tachycardia (heart rate 126 bpm) despite metoprolol 100 mg daily, what is the appropriate evaluation and management?

Immediate Evaluation and Management

In this 86-year-old patient with persistent tachycardia (126 bpm) despite metoprolol 100 mg daily, you must first determine the underlying rhythm with a 12-lead ECG, then assess for tachycardia-induced cardiomyopathy and optimize rate control by adding digoxin or a nondihydropyridine calcium channel blocker, or consider switching to combination therapy.

Step 1: Identify the Rhythm and Underlying Cause

Obtain a 12-lead ECG immediately to distinguish between:

• Atrial fibrillation/flutter (most common in elderly)
• Sinus tachycardia (suggests underlying pathology)
• Other supraventricular tachycardias

Check for precipitating factors:

• Volume status (dehydration, heart failure)
• Infection/sepsis
• Anemia
• Thyroid dysfunction
• Pulmonary embolism
• Medication effects or withdrawal

Step 2: Assess for Tachycardia-Induced Cardiomyopathy

This is critical. Persistent tachycardia >100 bpm can cause reversible cardiomyopathy 1. Obtain:

• Echocardiogram to assess left ventricular ejection fraction
• BNP level if heart failure suspected

Tachycardia-induced cardiomyopathy should be suspected when LV dysfunction occurs with persistent inappropriate tachycardia without another identified cause 1.

Step 3: Optimize Rate Control

Target Heart Rate

Aim for resting heart rate <80 bpm 1. The current rate of 126 bpm is unacceptably high and risks progressive cardiac dysfunction.

Medication Strategy

For Atrial Fibrillation/Flutter:

The metoprolol 100 mg daily dose is already substantial. Rather than increasing beta-blocker further (which risks bradycardia, hypotension, or fatigue in an 86-year-old), add digoxin 2, 3:

• Digoxin is particularly effective for rate control at rest in elderly patients 2
• Combination of digoxin plus beta-blocker is reasonable to control heart rate both at rest and during exercise 2, 3
• Start digoxin 0.125 mg daily (lower dose in elderly due to reduced renal function)
• Monitor digoxin level and renal function

Alternative option: Add diltiazem or verapamil 2, 3:

• Diltiazem 120-180 mg daily (long-acting formulation)
• Caution: Avoid if patient has heart failure with reduced ejection fraction or hypotension 3
• Do not combine with beta-blocker if patient has decompensated heart failure 3

For Persistent Sinus Tachycardia:

This suggests an underlying problem that must be addressed:

• Treat the underlying cause (infection, anemia, volume depletion, etc.)
• If no reversible cause found and cardiomyopathy present, consider adding digoxin or switching to carvedilol
• Amiodarone, digoxin, or rate-limiting calcium channel blockers may be considered if beta-blockers don't achieve target heart rates 1

Step 4: Consider Referral for Advanced Therapies

Refer to electrophysiologist if 1:

• Persistent tachyarrhythmias despite optimal medical therapy
• Heart failure symptoms develop or worsen
• AV node ablation with pacing may be reasonable when pharmacological therapy is insufficient or not tolerated 2, 3

Critical Pitfalls to Avoid

1. Do not simply increase metoprolol dose blindly – at 100 mg daily, you're approaching maximum tolerated doses in elderly patients, and side effects (bradycardia, hypotension, fatigue) become problematic 4

2. Do not miss tachycardia-induced cardiomyopathy – this is reversible with adequate rate control, but delayed recognition leads to irreversible damage 1, 5

3. Monitor for bradycardia – elderly patients are at increased risk for sinus node dysfunction and heart block with rate-control medications 4

4. Check renal function before adding digoxin – elderly patients often have reduced creatinine clearance requiring dose adjustment 6

5. Avoid calcium channel blockers if heart failure with reduced EF is present – they can precipitate decompensation 3

Monitoring Plan

• Repeat ECG after medication adjustment
• 24-hour Holter monitor to assess average heart rate and adequacy of rate control during activity 2
• Repeat echocardiogram in 3-6 months if cardiomyopathy present to assess for recovery 1
• Check electrolytes, renal function, and digoxin level (if used) within 1-2 weeks